Division of General Internal Medicine, University of Colorado School of Medicine, Aurora, CO, United States.
Drug Alcohol Depend. 2013 Aug 1;131(3):263-70. doi: 10.1016/j.drugalcdep.2012.11.018. Epub 2013 Jan 5.
Pharmaceutical opioid related deaths have increased. This study aimed to place pharmaceutical opioid overdose deaths within the context of heroin, cocaine, psychostimulants, and pharmaceutical sedative hypnotics examine demographic trends, and describe common combinations of substances involved in opioid related deaths.
We reviewed deaths among 15-64 year olds in the US from 1999-2009 using death certificate data available through the CDC Wide-Ranging Online Data for Epidemiologic Research (WONDER) Database. We identified International Classification of Disease-10 codes describing accidental overdose deaths, including poisonings related to stimulants, pharmaceutical drugs, and heroin. We used crude and age adjusted death rates (deaths/100,000 person years [p-y] and 95% confidence interval [CI] and multivariable Poisson regression models, yielding incident rate ratios; IRRs), for analysis.
The age adjusted death rate related to pharmaceutical opioids increased almost 4-fold from 1999 to 2009 (1.54/100,000 p-y [95% CI 1.49-1.60] to 6.05/100,000 p-y [95% CI 5.95-6.16; p<0.001). From 1999 to 2009, pharmaceutical opioids were responsible for the highest relative increase in overdose death rates (IRR 4.22, 95% CI 3.03-5.87) followed by sedative hypnotics (IRR 3.53, 95% CI 2.11-5.90). Heroin related overdose death rates increased from 2007 to 2009 (1.05/100,000 persons [95% CI 1.00-1.09] to 1.43/100,000 persons [95% CI 1.38-1.48; p<0.001). From 2005-2009 the combination of pharmaceutical opioids and benzodiazepines was the most common cause of polysubstance overdose deaths (1.27/100,000 p-y (95% CI 1.25-1.30).
Strategies, such as wider implementation of naloxone, expanded access to treatment, and development of new interventions are needed to curb the pharmaceutical opioid overdose epidemic.
药物类阿片相关死亡人数增加。本研究旨在将药物类阿片过量死亡置于海洛因、可卡因、苯丙胺类兴奋剂和药物类镇静催眠药的背景下,研究人口统计学趋势,并描述与阿片类药物相关死亡相关的常见物质组合。
我们使用通过疾病预防控制中心广域在线流行病学研究(WONDER)数据库获得的死亡证明数据,回顾了 1999 年至 2009 年期间美国 15-64 岁人群的死亡情况。我们确定了描述意外药物过量死亡的国际疾病分类-10 代码,包括与兴奋剂、药物和海洛因有关的中毒。我们使用未经调整和年龄调整的死亡率(每 10 万人年的死亡人数/100,000 人[100,000 人年的死亡人数(95%置信区间[CI])和多变量泊松回归模型,得出发病率比;IRR)进行分析。
从 1999 年到 2009 年,与药物类阿片相关的年龄调整死亡率几乎增加了 4 倍(1.54/100,000 p-y[95%CI 1.49-1.60]至 6.05/100,000 p-y[95%CI 5.95-6.16;p<0.001)。从 1999 年到 2009 年,药物类阿片类药物是导致药物过量死亡率相对增幅最高的药物(IRR 4.22,95%CI 3.03-5.87),其次是镇静催眠药(IRR 3.53,95%CI 2.11-5.90)。海洛因相关药物过量死亡率从 2007 年到 2009 年增加(每 10 万人 1.05/100,000 人[95%CI 1.00-1.09]至每 10 万人 1.43/100,000 人[95%CI 1.38-1.48;p<0.001)。从 2005 年到 2009 年,药物类阿片类药物和苯二氮䓬类药物的联合使用是最常见的导致多药物过量死亡的原因(每 10 万人年 1.27/100,000 p-y(95%CI 1.25-1.30)。
需要采取策略,例如更广泛地实施纳洛酮、扩大治疗机会和开发新的干预措施,以遏制药物类阿片类药物过量流行。